V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210038674 | 210005804 | null | 76.2 | Curative (C) | 2015-01-25 | 2015-06-25 | ALL UKALL2011 Del Intens B Pt2 | Y | N | 210007768 | UKALL2011 |
| 210038675 | 210005850 | 1.61 | 19.3 | Curative (C) | 2015-11-19 | 2015-11-19 | ALL UKALL2011 IndB Std Dex (PegAsp) | N | N | 210007896 | UKALL2011 |
| 210038676 | 210005888 | 1.69 | 19.6 | Curative (C) | 2014-08-31 | 2014-09-15 | ALL UKALL2011 Maintenance C1 | Y | N | 210008060 | UKALL2011 |
| 210038677 | 210005898 | 1.56 | 15.7 | Curative (C) | 2014-09-18 | 2015-04-16 | ALL UKALL2011 Maintenance A1 | Y | null | 210008074 | UKALL2011 |
| 210038679 | 210018052 | 1.51 | null | null | 2014-04-13 | 2015-02-15 | ALL UKALL2011 Maintenance A1 | N | null | 210008211 | UKALL2011 |
| 210038680 | 210018068 | 1.74 | 50 | Curative (C) | 2017-03-23 | 2017-08-15 | ALL UKALL2011 Maintenance A1 | Y | N | 210008355 | UKALL2011 |
| 210038681 | 210032900 | 1.07 | 19.4 | Curative (C) | 2017-06-24 | 2018-01-03 | ALL UKALL2011 Maintenance A1 | Y | Y | 210008413 | UKALL2011 |
| 210038682 | 210005995 | 1.8 | null | Curative (C) | 2017-08-07 | 2017-08-12 | ALL UKALL2011 Maintenance A1 | 02 | N | 210008455 | UKALL2011 |
| 210038683 | 210006005 | 0 | 52.5 | Curative (C) | 2017-02-17 | 2017-08-04 | ALL UKALL2011 Maintenance A4 | 2 | N | 210008484 | UKALL 2011 |
| 210038685 | 210006026 | 0 | 73.2 | Curative (C) | 2020-06-27 | 2020-07-17 | ALL UKALL2011 Maintenance B1 | Y | N | 210008519 | UKALL 2011 |
| 210038686 | 210037812 | null | 57.2 | Curative (C) | 2015-12-22 | 2016-08-08 | ALL UKALL2011 TRIAL | y | N | 210008526 | UKALL 2011 |
| 210038687 | 210006040 | 1.39 | 53 | Curative (C) | null | 2018-09-03 | ALL UKALL2011 TRIAL | null | N | 210008549 | UKALL 2011 |
| 210038688 | 210006055 | 0 | 54 | Curative (C) | 2016-11-27 | 2016-12-06 | ALL UKALL2011 TRIAL | Y | N | 210008601 | UKALL 2011 |
| 210038689 | 210006089 | 0 | 62 | Adjuvant (A) | 2014-11-15 | 2014-11-16 | ALL UKALL2011 Std Int Maint B | N | N | 210008769 | UKALL 2011 |
| 210038690 | 210018164 | 0 | 17.4 | Curative (C) | 2015-11-25 | 2016-03-19 | ALL UKALL2011 TRIAL | N | N | 210008823 | UKALL 2011 |
| 210038691 | 210018172 | 1.69 | 79.45 | Curative (C) | 2019-06-21 | 2019-09-05 | Methotrexate intrathecal | N | null | 210008880 | METHOTREXATE INTRATHECAL |
| 210038692 | 210006176 | 0 | 0 | Curative (C) | 2017-06-18 | 2017-11-19 | Methotrexate intrathecal | Y | N | 210009255 | METHOTREXATE INTRATHECAL |
| 210038693 | 210006222 | 1.04 | 64 | null | 2016-06-04 | 2017-01-29 | Methotrexate Intrathecal (any age) | Y | null | 210009402 | METHOTREXATE INTRATHECAL |
| 210038694 | 210006241 | null | 48.9 | Curative (C) | 2017-08-02 | 2017-09-22 | Methotrexate intrathecal | N | N | 210009453 | METHOTREXATE INTRATHECAL |
| 210038695 | 210006284 | null | 27.5 | Curative (C) | 2015-01-06 | 2015-03-25 | Methotrexate intrathecal | N | N | 210009681 | METHOTREXATE INTRATHECAL |
| 210038696 | 210006298 | null | 0 | Curative (C) | 2016-07-26 | 2017-02-17 | Methotrexate Intrathecal (any age) | Y | N | 210009764 | METHOTREXATE INTRATHECAL |
| 210038697 | 210006307 | null | 0 | Curative (C) | 2014-06-06 | 2014-06-21 | Methotrexate Intrathecal (any age) | Y | N | 210009769 | METHOTREXATE INTRATHECAL |
| 210038698 | 210006320 | 0 | 33.4 | Curative (C) | 2018-01-20 | 2018-01-27 | Methotrexate intrathecal | 02 | N | 210009784 | METHOTREXATE INTRATHECAL |
| 210038699 | 210006339 | 1.81 | 32.6 | Curative (C) | 2016-11-09 | 2017-06-28 | Methotrexate Intrathecal (any age) | Y | N | 210009828 | METHOTREXATE INTRATHECAL |
| 210038700 | 210006347 | null | 0 | Curative (C) | 2016-05-06 | 2016-12-16 | Methotrexate intrathecal | Y | Y | 210009833 | METHOTREXATE INTRATHECAL |
| 210038701 | 210006372 | 0 | 96.7 | Curative (C) | 2016-03-06 | 2016-03-14 | Methotrexate intrathecal | N | N | 210009866 | METHOTREXATE INTRATHECAL |
| 210038702 | 210006422 | 1.11 | 64 | Curative (C) | null | 2016-11-01 | Methotrexate intrathecal | N | null | 210010026 | METHOTREXATE INTRATHECAL |
| 210038703 | 210006427 | 1.81 | 99.4 | Curative (C) | 2015-05-30 | 2015-12-03 | UKALL14- Ph 2 Induction | Y | N | 210010032 | UKALL2014 |
| 210038704 | 210018400 | 1.9 | 94.9 | Curative (C) | 2016-10-30 | 2017-01-25 | UKALL14- Cons Cycle 1 | N | N | 210010067 | UKALL2014 |
| 210038705 | 210006445 | 1.84 | 57.9 | Curative (C) | null | 2017-04-02 | UKALL14- Intens/CNS Proph | N | N | 210010115 | UKALL2014 |
| 210038706 | 210006467 | 1.8 | 87 | Curative (C) | 2015-12-05 | 2016-04-07 | UKALL 14 TRIAL | Y | null | 210010142 | UKALL2014 |
| 210038707 | 210006471 | null | 86.9 | Curative (C) | 2015-07-28 | 2015-10-16 | UKALL14- Maintenance | 01 | N | 210010163 | UKALL2014 |
| 210038708 | 210006478 | 1.86 | 93.5 | Curative (C) | 2017-03-29 | 2017-08-03 | UKALL14- Ph 2 Induction | Y | N | 210010194 | UKALL2014 |
| 210038709 | 210025695 | 1.49 | 67.5 | Curative (C) | 2018-04-29 | 2020-02-11 | UKALL14- Cons Cycle 2 | Y | null | 210010213 | UKALL2014 |
| 210038711 | 210006519 | 0 | 7.3 | Curative (C) | 2015-11-10 | 2016-06-28 | CNS Medbl HR Carboplatin/Vinc/Cyclophos/GCSF | Y | N | 210010330 | NOT MATCHED |
| 210038712 | 210006534 | null | 19.6 | Curative (C) | 2017-02-07 | 2018-01-11 | ALL UKALL2011 Del Intens A Pt2 | N | N | 210010379 | NOT MATCHED |
| 210038713 | 210006543 | 1.29 | null | Curative (C) | 2018-01-05 | 2018-03-07 | ALL Interfant 06 MARMA: Ph II PAsp | N | null | 210010396 | NOT MATCHED |
| 210038714 | 210006550 | 0 | 66.5 | Adjuvant (A) | 2018-12-08 | 2019-01-05 | CNS Infant MBL Car/Etop | 02 | N | 210010402 | NOT MATCHED |
| 210038715 | 210006614 | 1.62 | 60.9 | Curative (C) | 2016-02-23 | 2016-03-07 | PCV | 02 | N | 210010604 | PCV |
| 210038716 | 210006675 | 1.73 | 56.9 | Palliative (P) | 2018-09-06 | 2018-09-09 | PCV | N | N | 210010778 | PCV |
| 210038717 | 210018566 | 1.82 | 79.3 | Palliative (P) | 2018-09-14 | 2018-09-17 | PCV | N | N | 210010787 | PCV |
| 210038718 | 210006723 | 1.6 | 86.5 | Adjuvant (A) | 2015-05-29 | 2015-05-29 | PCV | N | N | 210010917 | PCV |
| 210038719 | 210006746 | 1.75 | 58.7 | Curative (C) | 2016-09-10 | 2016-10-21 | Temozolomide + RT | null | N | 210010965 | TEMOZOLOMIDE + RT |
| 210038720 | 210006764 | 1.63 | null | Curative (C) | 2019-02-05 | 2019-02-06 | Trial Unspecified | Y | N | 210010978 | TRIAL |
| 210038721 | 210033074 | 1.89 | 109.6 | null | 2018-01-12 | 2018-05-09 | Rituximab | Y | N | 210011203 | RITUXIMAB |
| 210038722 | 210006906 | 1.69 | 107 | Disease modification (D) | 2017-10-15 | 2018-05-09 | Rituximab | N | N | 210011405 | RITUXIMAB |
| 210038723 | 210006925 | 1.62 | 53 | Curative (C) | 2018-09-12 | 2018-11-14 | FCR Oral - Cycle 1 | Y | N | 210011458 | FCR |
| 210038724 | 210007027 | null | 58.8 | Curative (C) | 2019-06-14 | 2019-08-03 | CHLORAMBUCIL + RITUXIMAB | Y | N | 210011965 | CHLORAMBUCIL + RITUXIMAB |
| 210038725 | 210018915 | 1.59 | null | Curative (C) | 2018-12-22 | 2019-01-02 | R Chlorambucil | Y | N | 210012572 | CHLORAMBUCIL + RITUXIMAB |
| 210038726 | 210007595 | 0 | 99.7 | Palliative (P) | 2020-06-20 | 2020-06-20 | Imatinib 600mg | N | N | 210013640 | IMATINIB |